STOCKHOLM, May 25, 2022 /PRNewswire/ A new study with TikoMed's platform lead clinical drug candidate ILB, provides positive safety and tolerability results and the first clinical evidence
TikoMed AB reports positive phase II clinical data for the treatment of Amyothropic Lateral Sclerosis in data published by PLOS ONE prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
STOCKHOLM, April 28, 2022 /PRNewswire/ Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments for Alzheimer's disease by specifically targeting neurotoxic amyloid